Trial intelligence / Profile preview

V0498 vs Placebo in Acute Sore Throat Pain

NCT01785862Phase 3Completed

Sponsor
Pierre Fabre Laboratories
Start
Feb 2013
Primary completion
Jun 2013
Modality
Small Molecules
Countries
4
01

Overview

Phase 3, randomised, double-blind trial in acute pharyngitis comparing Ibuprofen 25 mg with Placebo (2 arms). Primary endpoint: Total Pain relief over 2 hours. Started Feb 2013; status: completed.

02

Drugs

ibuprofen
03

Conditions

acute pharyngitis

Beyond the preview

Go deeper on NCT01785862.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01785862.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call